Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptor

Jingjing Zhao(Shanghai University of Sport), Hongkui Deng(Peking University)
OncoImmunology
October 5, 2023
Cited by 8


Related Papers